Cargando…
Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting
Objective: Suvorexant is an orexin receptor antagonist and is effective in inducing sleep. We hypothesized that Suvorexant would reduce the incidence of postoperative delirium (POD) after coronary artery bypass grafting (CABG). Methods: We reviewed 88 patients (12 women, mean age: 69.3 ± 2.5 years)...
Autores principales: | Tamura, Kiyoshi, Maruyama, Toshiyuki, Sakurai, Syogo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388307/ https://www.ncbi.nlm.nih.gov/pubmed/30089761 http://dx.doi.org/10.5761/atcs.oa.18-00038 |
Ejemplares similares
-
Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017) -
Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020) -
Impact of malnutrition on postoperative delirium development after on pump coronary artery bypass grafting
por: Ringaitienė, Donata, et al.
Publicado: (2015) -
Cardiac Delirium Index for Predicting the Occurrence of Postoperative Delirium in Adult Patients After Coronary Artery Bypass Grafting
por: Lechowicz, Kacper, et al.
Publicado: (2021) -
Effectiveness of Endovenous Radiofrequency Ablation for Elderly Patients with Varicose Veins of Lower Extremities
por: Tamura, Kiyoshi, et al.
Publicado: (2019)